Artificial intelligence is becoming the primary interface through which pharmaceutical information is accessed and interpreted. However, most pharma content ecosystems remain optimized for search engines and human readers — not for AI systems that now determine which treatments are surfaced, described, and remembered. This misalignment is already creating measurable consequences. While user behavior remains brand-led, AI-generated responses are predominantly INN-led.…